The Middle EAST Efficacy Testing Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including the increasing demand for efficacy testing in pharmaceuticals and biotechnology, the rising prevalence of infectious diseases, and the growing emphasis on regulatory...